173
Participants
Start Date
November 3, 2015
Primary Completion Date
April 20, 2018
Study Completion Date
May 29, 2018
Placebo
Participants received matching placebo LIN liquid solution or solid capsules, orally, 30 minutes before evening meal, once daily for 4 weeks.
LIN Dose A
Participants received LIN 9 or 18 ug liquid solution or solid capsules, orally, 30 minutes before evening meal, once daily for 4 weeks.
LIN Dose B
Participants received LIN 18 or 36 ug liquid solution or solid capsules, orally, 30 minutes before evening meal, once daily for 4 weeks.
LIN Dose C
Participants received LIN 36 or 72 ug liquid solution or solid capsules, orally, 30 minutes before evening meal, once daily for 4 weeks.
LIN 145 µg
Participants received LIN 145 µg, liquid solution or solid capsules, 30 minutes before evening meal, once daily for 4 weeks.
Columbia University Medical Center and Morgan Stanley, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Preferred Primary Care Physicians, Inc., Pittsburgh
Montgomery Medical Inc., Smithfield
Frontier Clinical Research, LLC, Scottdale
Pediatric Care Specialists, Johnstown
St. Christopher's Hospital for Children, Philadelphia
University of Maryland Children's Hospital, Baltimore
Pediatric Specialists of Virginia, Fairfax
Virginia Tech Carilion School of Medicine Pediatric, Roanoke
Asheboro Research Associates, Asheboro
University of North Carolina at Chapel Hill, Chapel Hill
Capital Pediatrics and Adolescent Center PLLC, Raleigh
Coastal Pediatric Research, Charleston
Coastal Pediatrics Associates, Mt. Pleasant
Sleepcare Clinical Research Institute, Stockbridge
Children's Center for Digestive Health Care LLC, Atlanta
Homestead Research Institute, Homestead
RM Medical Research, Homestead
Advanced Medical Research Center, Miami
Nova Southeastern University, Fort Lauderdale
SCORE Physician Alliance, LLC, St. Petersburg
GI Associates and Endoscopy Center, Jackson
Kentucky Pediatric/ Adult Research, Bardstown
Kosair Children's Hospital - Pediatric Clinical Research Unit, Louisville
Michael W. Simon, MD, PSC, Nicholasville
Ohio Pediatric Research Association, Dayton
Riley Hospital for Children at Indiana University Health, Indianapolis
University Of Minnesota, Minneapolis
Craig A. Speigel, MD, Bridgeton
Heartland Research Associates, LLC, Wichita
Midwest Children Health Research Institute, Lincoln
Midwest Children Health Research Institute, Lincoln
Willis-Knighton Physician Network, Shreveport
HealthStar Research, LLC, Hot Springs
Applied Research Center of Arkansas, Little Rock
IPS Research Company, Oklahoma City
ClinPoint Trials, Waxahachie
Cook Children's Medical Center, Fort Worth
Texas Children's Hospital/Baylor College Medicine, Houston
Houston Clinical Research Associates, Houston
Sun Research Institute, San Antonio
Southwest Children's Research Associates, P.A., San Antonio
Colorado Springs Health Partners, HCP-Clinical Research, LLC, Colorado Springs
Foothill Family Clinic South / J. Lewis Research, Inc., Salt Lake City
ACTCA, Inc, Los Angeles
Children's Hospital Los Angeles, Los Angeles
Center for Clinical Trials, LLC, Paramount
Ark Clinical Research, Long Beach
Orange County Research Institute, Ontario
UCSD Rady Children's Hospital, San Diego
WCCT Global, LLC, Costa Mesa
Advanced Research Center, Anaheim
Kindred Medical Institute for Clinical Trials, LLC, Corona
Ventura Clinical Trials, Ventura
University of California at San Francisco, San Francisco
Seattle Children's Hospital, Seattle
Massachusetts General Hospital, Boston
Goryeb Children's Hospital, Morristown
Rhode Island Hospital, Providence
Stollery Children's Hospital, Edmonton
Children's Hospital of Western Ontario, London
Lead Sponsor
Collaborators (1)
Ironwood Pharmaceuticals, Inc.
INDUSTRY
Forest Laboratories
INDUSTRY